Australia's largest stock trading and investment forum Australia's #1 stock forum

AVE

Click for more information

0.00%

0.4¢ avecho biotechnology limited

Critical six months, page-2

First 2 Last

Share
Profile

Follow
Virgon

431 Posts.

33

09/11/22

08:52

Post #: 64662517
Share

Originally posted by FrankieAlfie: ↑

All very quiet with ave. Quiet before the storm?
phase 3 soft gel insomnia ethics approval expected before years end. Dosing first quarter of 2023.
channel 9 had a report on a cbd trial for insomnia. Don't think it was ave but it looked very similar. Shame we may have missed first mover status...
lambert institute-using cbg phase 2 trial should have results end of q1 2023
canine study - report on absorption rates with food... should be results very soon
perland - phase 1 b osteoarthritis study - q1 2023...
and the mysterious unknown indication trial by my research it is in the dermatology space...
unfortunately the lack of news around team saas suggests it's hit some sort of road block and knowing aves history it's a safe bet that it won't progress

Expand

Yes I think I might have to cut my losses and run.

AVE Price at posting: 0.8¢ Sentiment: Hold Disclosure: Held
4 Upvote

0 Great analysis

Reply

There are more pages in this discussion • 20 more messages in this thread...

First 2 Last

Add AVE (ASX) to my watchlist

(20min delay)
Last 0.4¢		Change 0.000(0.00%)		Mkt cap ! $11.09M

Open	High	Low	Value	Volume
0.4¢	0.4¢	0.3¢	$2.112K	618.9K

Buyers (Bids)

No.	Vol.	Price($)
42	65007105	0.3¢

Sellers (Offers)

Price($)	Vol.	No.
0.4¢	39319923	21

View Market Depth

No.	Vol.	Price($)
42	65007105	0.003
26	69485176	0.002
11	58000009	0.001
0	0	0.000
0	0	0.000

Price($)	Vol.	No.
0.004	39319923	21
0.005	57904777	25
0.006	31181008	17
0.007	9565420	9
0.008	6483888	6

Last trade - 15.43pm 23/05/2024 (20 minute delay)

AVE (ASX) Chart